ReviewCancers2021

The Urokinase Receptor (uPAR) as a "Trojan Horse" in Targeted Cancer Therapy: Challenges and Opportunities.

Virginia Metrangolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.